Somaxon Pharmaceuticals (SOMX) Posts Q4 Loss of 21c/Share, Inline with the Street
Tweet Send to a FriendGet Alerts SOMX Hot Sheet
Price: $3.00 --0%
EPS Growth %: -80.6%
Financial Fact:
Selling, general and administrative: 4.38M
Today's EPS Names:
ATU, CRWS, CLC, More
EPS Growth %: -80.6%
Financial Fact:
Selling, general and administrative: 4.38M
Today's EPS Names:
ATU, CRWS, CLC, More
Trade SOMX Now!
Somaxon Pharmaceuticals, Inc. (NASDAQ: SOMX) reported Q4 EPS of ($0.21), in-line with the analyst estimate of ($0.21). Revenue for the quarter came in at $3.9 million versus the consensus estimate of $4.42 million.
Lowered its FY12 total non-GAAP operating expenses to $15-$16 million.
For earnings history and earnings-related data on Somaxon Pharmaceuticals, Inc. (SOMX) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Lowered its FY12 total non-GAAP operating expenses to $15-$16 million.
For earnings history and earnings-related data on Somaxon Pharmaceuticals, Inc. (SOMX) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Five Below (FIVE) Tops Q1 EPS by 1c, Boosts FY13 Outlook
- Linktone Ltd. (LTON) Q1 Profit Slips to 10c/ADS
- American Superconductor (AMSC) Reports In-Line Q4 EPS; Guides Q1
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
